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Introduction
The normal aorta expands to accommodate a portion of the ejected 
blood during cardiac contraction and then recoils during cardiac 
relaxation. This capacitance, or Windkessel function, of the aorta 
reduces systolic pressure and maintains pressure and peripheral 
perfusion during diastole. In several conditions — including aging, 
autoimmune diseases, cigarette smoking, diabetes, obesity, and 
hypertension — the aorta stiffens, leading to loss of the Windkessel 
function and systolic hypertension. Pulse wave velocity (PWV), a 
surrogate measure of aortic stiffness, predicts untoward outcomes 
in aged and hypertensive humans (1, 2). A recent analysis of the 
Framingham population indicates that aortic stiffening precedes 
hypertension and that higher forward pressure wave amplitude, a 
hallmark of aortic stiffening, is associated with increased risk for 
incident cardiovascular diseases (3, 4).
A common feature of many conditions associated with aortic 
stiffening is vascular oxidant stress. Clinically, plasma levels of 
myeloperoxidase and F2-isoprostanes correlate with arterial stiff-
ening in humans (5). Studies in experimental animals have impli-
cated ROS in fibrotic changes in blood vessels, lungs, skin, and 
other tissues (6, 7). In addition to oxidative events, chronic inflam-
mation is associated with arterial stiffness in humans (8–10). 
Patients with systemic lupus erythematosus, rheumatoid arthritis, 
and psoriasis exhibit increased aortic stiffness, and TNF-α antag-
onists improve parameters of aortic stiffness in patients with rheu-
matoid arthritis (11, 12). We have shown that hypertension is asso-
ciated with the infiltration of immune cells into the adventitia and 
periadventitial fat, as well as the activation of T cells that release 
proinflammatory cytokines such as IL-17A, IFN-γ, and TNF-α (13, 
14). IL-17A induces collagen synthesis in fibroblasts via activation 
of p38 MAP kinase (15). IFN-γ also promotes hypertension-related 
fibrosis in the heart, arteries, and the kidney (16).
A potential mechanism linking oxidative injury to immune 
activation and inflammation relates to modification of self-pro-
teins. In particular, isoketals — alternatively referred to as isole-
vuglandins or γ-ketoaldehydes — are formed from fatty acid oxi-
dation and react with protein lysines to form oxidized pyrrole 
adducts. These modified proteins become auto-antigens and can 
elicit antibody formation (17). We have recently shown that hyper-
tension is associated with accumulation of isoketal-adducted 
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tein adducts, vascular inflammation, aortic stiffening, renal dys-
function, and hypertension. These experiments provide new insight 
into how diverse conditions diminish aortic compliance, alter renal 
function, and ultimately cause hypertension. These findings also 
show how vascular diseases associated with vascular oxidative 
injury can lead to systemic immune activation and inflammation.
Results
Chronic vascular oxidative stress induces aortic stiffening and hyper-
tension. As an initial approach to determine if vascular oxidative 
stress promotes aortic stiffening, we studied tgsm/p22phox mice. 
These animals have smooth muscle–targeted overexpression of 
p22phox, a docking subunit of all murine NADPH oxidase catalytic 
subunits (19). Vessels from these mice exhibit increased vascular 
proteins within DCs. These adducts markedly enhance DC sur-
face expression of the costimulatory molecules CD80 and CD86, 
as well as cytokine production (18). Moreover, DCs modified in 
this fashion robustly drive T cell activation and can prime hyper-
tension when adoptively transferred to naive mice. The mech-
anisms leading to DC acquisition of isoketal-adducted proteins 
remain undefined. In particular, it is unknown if DCs can acquire 
oxidatively modified proteins produced by other cells; however, 
such a process could link oxidative injury in other cells to immune 
activation and might explain how oxidative stress leads to vascular 
inflammation and, ultimately, aortic stiffening.
In the present studies, we employed mice with chronic vascular 
oxidative stress to define a pathway that links oxidative damage to 
immune activation via formation of immunoreactive isoketal-pro-
Figure 1. Tgsm/p22phox mice develop age-related aortic stiffening and hypertension. (A) Effects of aging on vascular collagen deposition in WT and tgsm/p22phox 
mice. Perfusion-fixed sections of the thoracic aortas were sectioned (6 μm) and stained with Masson’s trichome to highlight collagen (blue). Areas within 
the red boxes were magnified (×20) and shown below the original images (×6). Scale bars: 100 μm. (B) Adventitial collagen area was quantified by planim-
etry. #P < 0.05 vs. WT; **P < 0.01 vs. 3 months. (C) Aortic collagen quantification by hydroxyproline assay. (D and E) Freshly isolated aortas were mounted 
on a myograph system in Ca2+-free buffer to determine pressure-diameter relationships. Stress-strain relationships were constructed from intraluminal 
pressure, wall thickness, and inner and outer diameters. These parameters were measured at 25 mmHg step changes in pressure from 0–200 mmHg.  
**P < 0.01 vs. Tg 3 months; ##P < 0.01 vs. WT. (F and G) Telemetry blood pressure of WT and tgsm/p22phox mice at 3, 6, and 9 months of age. †P < 0.05 vs. Tg 6 
months; ††P <0.01 vs. Tg 6 months. Data were analyzed using 2-way ANOVA; n = 6–9.
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ure 1D). Aortas from 3-month-old tgsm/p22phox mice were similar to 
those of WT mice, but at 6 and 9 months of age, aortas from these 
mice demonstrated depressed pressure-diameter relationships. 
This was reflected by a leftward shift in the stress-strain curves 
(Figure 1E), indicating increased stiffness of the aortas of tgsm/p22phox 
mice at 6 and 9 months of age.
To confirm aortic stiffening in vivo, we measured PWV as 
previously described (20). At 3 months of age, PWV in WT and 
tgsm/p22phox mice was similar; however, with aging, this parameter 
increased in tgsm/p22phox mice but did not significantly change in 
WT mice (Supplemental Figure 1; supplemental material available 
online with this article; doi:10.1172/JCI80761DS1).
Nox1 expression and a 2-fold increase in vascular superoxide and 
hydrogen peroxide production (19). Masson’s trichrome stain-
ing revealed minimal collagen staining in the aorta of WT mice 
at either 3, 6, or 9 months of age (Figure 1, A and B). In contrast, 
aortic adventitial collagen content was increased in the tgsm/p22phox 
mice at 6 and 9 months of age. Hydroxyproline analysis confirmed 
that aortic collagen content was increased by about 2-fold at 6 and 
9 months of age in tgsm/p22phox mice (Figure 1C).
Mechanical properties of the aortas of WT and tgsm/p22phox mice 
were studied ex vivo in a pressurized vessel apparatus. Aortas 
from WT mice at 3, 6, and 9 months of age demonstrated identical 
increases in diameter as intraluminal pressure was increased (Fig-
Figure 2. Vascular oxidative stress induced by deletion of smooth muscle Sod3 promotes age-related aortic stiffening and hypertension. (A) Masson’s 
trichrome blue staining in 3-, 6-, and 9-month-old Sod3fl/fl Cre– and Sod3fl/fl Smmhc-Cre mice. Tamoxifen was administered at 3 mg/20 kg in corn oil via i.p. 
injection at 10 weeks of age. Images are ×20 magnification. Scale bars: 100 μm. (B) Aortic hydroxyproline content. (C and D) Pressure diameter relation-
ship and stress-strain relationships. (E and F) Blood pressure measured by radiotelemetry (n = 6–8). #P < 0.05 vs. Cre–/–; *P < 0.05 vs. Sod3fl/fl Smmhc Cre 
3 month; **P < 0.05 vs. Sod3fl/fl Smmhc-Cre 3 month. Aortic hydroxyproline content was analyzed using 2-way ANOVA. Pressure diameter relationships, 
stress-strain relationships, and blood pressures were analyzed using 1-way ANOVA with repeated measures.
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or quantified by hydroxyproline content (Figure 2, A and B). By 6 
months of age, mice with Sod3 deletion had a marked increase in 
adventitial collagen compared with Sod3fl/fl mice lacking Cre recom-
binase. This was associated with development of aortic stiffening 
(Figure 2, C and D) but no increase in blood pressure (Figure 2, E 
and F). By 9 months of age, the SOD3-deficient mice exhibited not 
only aortic stiffening, but also a significant elevation of blood pres-
sure (Figure 2, A–F). Collectively, these data recapitulate our finding 
in tgsm/p22phox mice and support a role of vascular ROS in promoting 
vascular fibrosis, aortic stiffening, and age-related hypertension.
Oxidative stress–induced vascular inflammation contributes to 
age-related hypertension. We and others have previously demon-
strated that vascular inflammation contributes to the develop-
ment of hypertension and aortic stiffening (13–16, 22). We there-
fore sought to determine if chronic oxidative stress promotes 
vascular inflammation in tgsm/p22phox mice. Flow cytometry of single 
cell suspensions revealed that total leukocytes, monocyte/macro-
phages, B cells, total T cells, and CD4+ and CD8+ T cell subsets 
were all increased in aortas of 6- and 9-month-old tgsm/p22phox mice 
compared with similarly aged WT mice (Figure 3, A–N). IHC 
using anti-CD3 indicated that T lymphocytes were predominantly 
Although aortic stiffening developed at 6 months of age in 
tgsm/p22phox mice, their blood pressure remained normal at this 
time. At 9 months of age, however, tgsm/p22phox mice developed 
moderate hypertension, while WT mice remained normotensive 
(Figure 1, F and G). Analysis of heart rate variability showed an 
increase in the low-frequency to high-frequency ratio (LF/HF) in 
both WT and tgsm/p22phox mice at 6 and 9 months of age, but this 
was not different between the genotypes (Supplemental Fig-
ure 2). Thus, in tgsm/p22phox mice, aortic stiffening precedes blood 
pressure elevation, mimicking the sequence of these events in 
humans. This increase in blood pressure does not seem to be 
related to increased sympathetic outflow.
The effects of oxidative stress on aortic stiffening and age- 
related hypertension were confirmed in mice with vascular smooth 
muscle–targeted deletion of the extracellular SOD (Sod3fl/fl Smmhc- 
Cre mice, another model of vascular oxidative stress (21). Deletion 
of Sod3 was induced at 10 weeks of age by injection of tamoxifen. 
As controls, Sod3fl/fl mice lacking Cre recombinase were also treated 
with tamoxifen. At 3 months of age, shortly after Sod3 deletion, 
there was no significant difference in aortic collagen between these 
2 groups of animals, as estimated by Masson’s trichrome staining 
Figure 3. Flow cytometry 
analysis of inflammatory 
cells in the aorta of WT and 
tgsm/p22phox mice. Single cell 
suspensions were prepared 
from freshly isolated mouse 
aortas via enzymatic digestion 
and mechanical dissociation. 
Live cell singlets were ana-
lyzed for vascular inflamma-
tory cells. (A–H) CD45+ total 
leukocytes, F4/80+ macro-
phages, CD19+ B lymphocytes, 
CD3+ T lymphocytes, and 
CD4+/CD8+T cell subsets were 
identified in the aorta of 
9-month-old WT (A–D) and 
tgsm/p22phox mice (E–H). (I–N) 
Quantification of infiltrating 
leukocyte subsets using 2-way 
ANOVA (n = 6–8). **P < 0.01 
vs. Tgsm/p22phox; #P < 0.05;  
##P < 0.01.
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revealed perivascular collagen deposition in the kidney of 9-month-
old tgsm/p22phox mice but not WT mice (Figure 6B). These changes in 
renal inflammation and fibrosis were paralleled by a decline in the 
capacity of mice to excrete a volume and sodium challenge. Mice 
received an i.p. injection of normal saline equal to 10% of their 
body weight, and the urine volume and sodium excreted in the sub-
sequent 4 hours was monitored as previously described (23, 24). 
This analysis revealed that tgsm/p22phox mice exhibited an accelerated 
decline in their ability to excrete this volume and sodium load with 
aging (Figure 6, C and D). Thus, chronic vascular oxidative stress 
initially causes vascular inflammation and subsequent renal inflam-
mation, fibrosis, and dysfunction. These perturbations of renal 
function temporally correspond to the elevation of blood pressure 
observed in these mice.
T lymphocytes are required for collagen deposition, aortic stiffen-
ing, and hypertension in mice with chronic vascular oxidative stress. 
Because T cells contribute to hypertension in other models, we 
crossed tgsm/p22phox mice with mice lacking the Rag-1–/– mice, to gen-
erate tgsm/p22phox × Rag-1–/– mice. Unlike tgsm/p22phox mice, tgsm/p22phox × 
Rag-1–/– mice did not develop collagen deposition (Figure 7, A–C), 
aortic stiffening (Figure 7, D and E), or hypertension (Figure 7, F 
located in the adventitia and perivascular fat of thoracic aortas 
in Tgsm/p22phox mice at 6 and 9 months of age, compared with age-
matched WT mice (Supplemental Figure 3).
In additional experiments, we examined the production of 
cytokines by aortic T cells using intracellular staining. At 3 months 
of age, the few T cells in the aorta of tgsm/p22phox mice produced min-
imal amounts of IFN-γ, IL-17A, or TNF-α; however, by 6 and 9 
months, the number of both CD8+ and CD4+ T cells in the aorta pro-
ducing these cytokines was significantly increased (Figure 4, A–G).
Chronic vascular oxidative stress promotes age-related renal inflam-
mation, fibrosis, and dysfunction. We considered the hypothesis that 
chronic vascular oxidative stress might predispose to renal inflam-
mation and dysfunction. Flow cytometry of kidney single cell suspen-
sions showed a significant increase in total leukocytes, monocyte/ 
macrophages, DCs, total T cells, and both CD4+ and CD8+ T cells 
at 9 months of age but not at earlier time points in tgsm/p22phox mice 
(Figure 5, A–G). IHC showed that CD3+ cells accumulate in the peri-
glomerular and perivascular regions of 9-month-old tgsm/p22phox mice. 
In contrast, there was minimal accumulation of immune cells, as 
assessed by either flow cytometry or IHC in aged WT mice (Figure 
6A). In parallel with T cell infiltration, Masson’s trichrome staining 
Figure 4. Production of cytokines 
by aortic T cells using intracellular 
staining. One million splenocytes 
were stimulated with ionomycin 
and phorbol myristate acetate and 
brefeldin A at 37°C for 5 hours. 
Intracellular staining was then per-
formed with the Cytofix/Cytoperm 
Plus fixation and permeabilization 
solution kit using anti–IL-17A and 
anti–IFN-γ antibodies. (A) Repre-
sentative images of IFN-γ– 
producing CD8+ T cells of WT 
and tgsm/p22phox mice at 3, 6, and 9 
months of age. (B–D) Quantifica-
tion of CD8+ T cells producing IFN-γ, 
IL-17A, and TNF-α. (E–G) Quantifica-
tion of CD4+ T cells producing IFN-γ, 
IL-17A, and TNF-α. *P < 0.01 vs. WT; 
**P < 0.01 vs. WT; #P < 0.05 vs. 6 
months; ##P <0.01 vs. 3 months. 
These data were analyzed using 
2-way ANOVA.
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and G). To further examine a role of T cells in aortic stiffening and 
hypertension in response to vascular oxidative stress, we adop-
tively transferred 2 × 107 T cells to tgsm/p22phox × Rag-1–/– mice at 3 
months of age and allowed them to survive until 9 months of age. 
Adoptive transfer of T cells restored collagen deposition, aortic 
stiffening, and blood pressure elevation in the tgsm/p22phox × Rag-1–/– 
mice, supporting an essential role of T cells in the development of 
aortic fibrosis and hypertension induced by chronic vascular oxi-
dative stress. Likewise, deficiency of Rag-1 protected mice from 
a decline in their ability to excrete a sodium and volume load at 
9 months of age, while this protection was lost in mice that had 
undergone adoptive transfer of T cells (Supplemental Figure 4).
Isoketals accumulate in the aorta and antigen presenting cells of 
tgsm/p22phox mice. Because pyrrole-modified proteins can act as auto-
antigens and stimulate inflammatory responses (17, 18), we sought 
to determine if chronic vascular oxidant stress promotes their for-
mation. We used stable isotope dilution liquid chromatography/
mass spectrometry (LC/MS) analysis of isoketal-lysyl-lactam to 
quantify isoketal-protein adducts in thoracic aortic homogenates of 
9-month-old mice (Figure 8A, red arrows). Aortic isoketal-protein 
adducts were markedly elevated in tgsm/p22phox mice compared with 
WT mice (Figure 8B). Flow cytometry of single cell suspensions 
confirmed a higher content of isoketal adducts in CD45– cells of 
the tgsm/p22phox aortas compared with aortas of WT mice at 3, 6, and 9 
months of age. These tended to increase in the transgenic mice, but 
this did not reach statistical significance (Supplemental Figure 5).
To further confirm the presence of isoketal-protein adducts 
in vessels of tgsm/p22phox mice, we performed immunohistochem-
ical staining using the single chain antibody D11 (18). Abundant 
isoketal-protein adducts were identified in aortas of 9-month-old 
tgsm/p22phox mice but not WT mice (Figure 8C). Treatment of mice 
from 4–9 months of age with either the SOD mimetic tempol or 
the isoketal scavenging agent 2-hydroxybenzylamine (2-HOBA) 
eliminated isoketal staining in the tgsm/p22phox mouse vessels.
In additional experiments, we found that isoketals also accu-
mulate in antigen presenting cells (APCs) of tgsm/p22phox mice. Using 
a recently described gating strategy (25), macrophages were identi-
fied as CD64+MerTK+, and DCs were selected from the remaining 
cells as CD11c+ and MHC-II+ cells (Supplemental Figure 6). Mono-
cytes were identified as CD11b+CD64+F4/80loSSClo cells. Virtually 
all monocytes were Ly-6C+, and most expressed MHC-II. Intracel-
lular staining for isoketals using D11 conjugated to Alexa Fluor 488 
revealed that DCs, macrophages, and to a smaller extent monocytes 
of 9-month-old tgsm/p22phox mice accumulate isoketal-protein adducts, 
while cells of age-matched WT animals do not (Figure 8, D–I). This 
was prevented by chronic treatment with either tempol or 2-HOBA.
We also analyzed the presence of isoketal adducts in peptides 
eluted from MHC-I using a dot blot analysis and the D11 antibody. 
Peptides from 9-month-old WT mice were devoid of such adducts; 
however, those eluted from DCs of aged tgsm/p22phox mice were clearly 
modified by isoketals (Figure 8J). Thus, DCs from mice with chronic 
vascular oxidative stress present oxidatively modified peptides.
Figure 5. Flow cytometry analy-
sis of renal leukocytes. Single cell 
suspensions were prepared from 
freshly isolated mouse kidneys 
via enzymatic digestion and 
mechanical dissociation. Live cell 
singlets were analyzed. (A) CD45+ 
total leukocytes, F4/80+ macro-
phages, CD11b+CD11c+ DCs, CD3+ 
T lymphocytes, and CD4+/CD8+ 
T cell subsets were identified in 
the aorta of 9-month-old WT and 
tgsm/p22phox mice. (B–G) Quantifi-
cation of infiltrating leukocyte 
subsets using 2-way ANOVA  
(n = 6–8). *P < 0.05; **P <0.01;  
#P < 0.05; ##P < 0.01.
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Scavenging of ROS prevents vascular inflammation, aortic stiffen-
ing, renal dysfunction, and hypertension in tgsm/p22phox mice. To deter-
mine if scavenging superoxide or isoketals prevents vascular oxida-
tive stress–induced aortic stiffening and hypertension, we treated 
mice with either tempol or 2-HOBA from 4–9 months of age and 
monitored blood pressure with telemetry. Both of these thera-
pies prevented aortic fibrosis in tgsm/p22phox mice at 6 and 9 months 
of age (Figure 9, A–C). Similarly, treatment with either tempol or 
2-HOBA prevented aortic stiffening and age-related hypertension 
(Figure 9, D–G). Treatment with either tempol or 2-HOBA also pre-
served the ability to excrete a sodium and volume challenge at 9 
months of age (Supplemental Figure 7). These data support a role 
of vascular ROS in promoting vascular fibrosis, aortic stiffening, 
and age-related hypertension. Despite the effectiveness of tempol 
and 2-HOBA in preventing aortic stiffening and hypertension, we 
found that these agents did not reverse these abnormalities if intro-
duced at 7 months of age (Supplemental Figure 8).
To determine if superoxide or isoketal scavenging reduced vas-
cular inflammation, we performed flow cytometry on the aortas of 
tgsm/p22phox mice treated with vehicle, tempol, or 2-HOBA from 4–9 
months of age. Both tempol and 2-HOBA markedly reduced the 
aortic infiltration of leukocytes (Figure 10, A–C). The infiltrating 
CD45+ total leukocytes, F4/80+ monocyte/macrophages, CD19+ B 
cells, CD3+ total T cells, and CD4+ and CD8+ T cell subsets were 
significantly reduced by either of these treatments (Figure 10, D–I).
Vascular oxidative stress promotes cytokine production by splenic 
T cells. We and others have previously shown that IL-17A and IFN-γ 
contribute to hypertension (14, 16, 26) and that IL-17A plays a critical 
role in aortic stiffening (15). We therefore sought to determine if T 
cells of mice with vascular oxidative stress produce IL-17A and IFN-γ. 
Splenic T cells from 9-month-old WT and tgsm/p22phox mice were ana-
lyzed by flow cytometry using intracellular staining for these cyto-
kines (Figure 11A). While WT T cells produced minimal amounts 
of IL-17A, 5% of CD4+ T cells and 10% of double-negative (CD3+/
CD4–/CD8–) T cells of tgsm/p22phox mice produced this cytokine (Figure 
11, B and D–F). Likewise, IFN-γ–producing cells were doubled in all 3 
subsets of T lymphocytes in tgsm/p22phox mice compared with WT (Fig-
ure 11, C and G–I). Treatment with tempol or 2-HOBA normalized 
T cell production of IL-17A and IFN-γ in tgsm/p22phox mice. These data 
suggest that vascular oxidative stress systemically activates T cells 
and promotes their proinflammatory cytokine production.
Protein homogenates of tgsm/p22phox mouse vessels are immunogenic. 
We have shown that isoketal-protein adducts promote maturation 
and activation of DCs in angiotensin II–induced hypertension and 
that these activated DCs can drive proliferation of T cells from 
angiotensin II–treated mice (18). To determine if proteins from 
the aortas of tgsm/p22phox mice are immunogenic, we prepared aortic 
homogenates from WT and tgsm/p22phox mice at 9 months of age. 
These were used to pulse naive DCs from WT mice for 2 hours 
and were then washed from the cells (Figure 12A). The pulsed DCs 
were then cocultured with 1 × 107 T cells isolated from the spleen 
of either WT or tgsm/p22phox mice and prelabeled with CFSE at a ratio 
of 1:10. Of note, T cells isolated from tgsm/p22phox mice, but not those 
from WT mice, survived and proliferated in response to the stim-
ulation of immunogenic protein homogenate of tgsm/p22phox mice, 
suggesting that preexposure to isoketal-adducted antigens in vivo 
Figure 6. Development 
of age-related renal 
inflammation, fibrosis, 
and dysfunction in  
tgsm/p22phox mice. (A and 
B) Consecutive 6-micron 
sections were obtained 
from paraffin-embedded 
mouse kidneys and were 
stained with anti-CD3 
and Masson’s trichrome 
blue. Images are ×20 
magnification. Scale 
bars: 100 μm. (C and D) 
Mice received a single 
i.p. injection of normal 
saline equal to 10% of 
body weight, and urine/
sodium excretion in the 
subsequent 4 hours 
were monitored. These 
data were analyzed with 
2-way ANOVA (n = 6–8).
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ity of their aortic protein, as indicated by the diminished survival, 
proliferation, and cytokine production of T cells in this assay.
To determine if DCs were functionally activated in these con-
ditions, we also evaluated the polarizing cytokines released into 
the medium. When DCs exposed to tgsm/p22phox aortic homogenates 
were cocultured with T cells isolated from tgsm/p22phox mice, there 
was a marked increase of GM-CSF, IL-1α, IL-1β, IL-6, TGF-β1, and 
TGF-β3 (Table 1). These increases were blunted when DCs were 
primed with aortic homogenates from tgsm/p22phox mice chronically 
primed these cells for clonal expansion upon a second challenge 
(Figure 12, B–I). Aortic homogenates of tgsm/p22phox mice, but not WT 
mice, supported survival of CD3+ (Figure 12, B and F), CD4+, and 
CD8+ T cells (Figure 12, C and G) when presented to T cells by DCs. 
DCs pulsed with tgsm/p22phox aortic homogenates also induced pro-
liferation of CD4+ (Figure 12, D and H) and to a lesser extent CD8+ 
T cells (Figure 12, E and I), and increased the release of IL-17A/F, 
IFN-γ, and TNF-α into the medium (Table 1). Chronic treatment of 
tgsm/p22phox mice with tempol or 2-HOBA reduced the immunogenic-
Figure 7. T cells mediate age-related aortic collagen deposition, aortic stiffening, and elevation of blood pressure in tgsm/p22phox mice. Pan T cells were 
isolated from the spleen of 3-month-old WT mice and adoptively transferred to age-matched tgsm/p22phox × Rag-1–/– mice to reconstitute T cell population. 
Mice were subsequently studied at 9 months of age. (A) Examples of aortic Masson’s trichrome blue staining. (B) Quantification of collagen staining by 
planimetry. (C) Quantification of aortic hydroxyproline levels. #P < 0.05. (D and E) Pressure diameter curves and stress strain relationships obtained using 
isolated aortic segments studied as in Figure 1. *P < 0.05 vs. Tgsm/p22phox × Rag-1–/–; **P < 0.01 vs. Tgsm/p22phox × Rag-1–/–; ##P < 0.01 vs. WT. (F and G) Telemetry 
recordings of blood pressures over 3 days. #P < 0.05 vs. WT. Collagen deposition was quantified using 1-way ANOVA. Aortic stiffness and blood pressure 
were analyzed using 1-way ANOVA with repeated measures (n = 6–8).
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Figure 8. Chronic vascular oxidative stress promotes isoketal-adduct formation. (A and B) Stable isotope dilution multiple reactions monitoring MS 
analysis of isoketal-lysine-lactam (IsoK-Lys) adducts in aortas of 9-month-old animals. Representative LC/MS chromatographs from pooled samples 
for each group (A). The left panel shows chromatographs for IsoK-Lys in samples, while the right panel shows chromatographs for [13C615N2] internal 
standards in the same samples. Mann-Whitney tests were employed for analysis. The bar graph in B shows mean data. (C) Fix-perfused mouse aortas 
were embedded in paraffin and subjected to IHC for isoketal staining. Images are ×20 magnification. Scale bars: 100 μm. (D–I) Intracellular staining 
for isoketals in spleen macrophages (D and E), DCs (F and G), and monocytes (H and I). These data were analyzed using 1-way ANOVA, n = 6. *P < 0.05; 
**P < 0.01. (J) DCs isolated from 9-month-old WT and tgsm/p22phox mice were exposed to weak acid to elute peptides presented on MHC-I complexes. The 
presence of isoketal-adducted peptides in the eluent was visualized by dot blot. Isoketal adducts were present in 3 of 4 tgsm/p22phox mice but not in WT 
mice (see Supplemental Figure 5C for full uncut gel).
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tional studies. First, we examined the degree of fibrosis and the 
presence of isoketal adducts and T cells in sections of human aor-
tas using staining with Masson’s trichrome, D11, and anti-CD3, 
respectively. Unlike mouse vessels, human aortas were often 
noted to contain collagen and T cells not only in the adventitia, but 
also in the media (Figure 13A). Despite this difference in species, 
we found that the severity of fibrosis was significantly correlated 
with the presence of isoketal adducts (Figure 13, A and B) and T 
cells (Figure 13, A and C) in human aortas. Additionally, there 
was also correlation between the presence of T cells and isoketal 
adducts (Figure 13, A and D).
treated with tempol or 2-HOBA, suggesting that superoxide and 
isoketals contribute to immunogenicity of vascular proteins. Inter-
estingly, tgsm/p22phox mouse aortic homogenates failed to induce DCs 
to produce these cytokines if they were cocultured with T cells from 
WT mice, suggesting that interactions with isoketal-primed T cells 
also promote DC activation. Other cytokines — such as IL-2, IL-12 
(p40), IL-12 (p70), IL-21, IL-23, and TGF-β2 — were either unde-
tectable or not differentially produced across treatment groups.
Evidence that the isoprostane/isoketal pathway contributes to 
aortic stiffening and inflammation in humans. To determine if our 
findings in mice have relevance to humans, we performed 2 addi-
Figure 9. Scavenging superoxide or isoketals prevents aortic collagen deposition, aortic stiffening and hypertension in tgsm/p22phox mice. Tgsm/p22phox mice 
received either no treatment, tempol, or 2-HOBA in the drinking water from 3–9 months of age. (A) Masson’s trichrome staining at ×20 magnification. 
Scale bars: 100 μm. (B and C) Mean data for quantification of collagen staining (B) and hydroxyproline content (C). *P < 0.05; **P < 0.01. (D and E) Pressure 
diameter and stress strain relationships for isolated aortic segments studied as in Figure 1. ##P < 0.01 vs. WT; **P < 0.01 vs. 2-HOBA. (F and G) Effect of 
antioxidant treatment on blood pressure in aged tgsm/p22phox mice. Collagen deposition was quantified using 1-way ANOVA. Aortic stiffness and blood pres-
sure were analyzed with 1-way ANOVA with repeated measurements (n = 6–8).
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Discussion
Our present study defines a new pathway in which vascular oxida-
tive stress promotes systemic inflammation via formation of immu-
nogenic isoketal-protein adducts. These act as autoantigens that are 
presented to T lymphocytes by APCs, leading to T cell activation. 
These activated T cells then infiltrate the vascular adventitia and 
release cytokines that induce collagen deposition, leading to aor-
tic stiffening, renal inflammation and dysfunction, and ultimately 
hypertension (Figure 14). Aortic stiffening accompanies several 
common conditions, including aging, hypertension, atheroscle-
rosis, overt diabetes, obesity, and cigarette smoking (5, 27–29). In 
many of these conditions, vascular oxidative stress is known to exist 
and might initiate the pathway delineated in this study.
A recent analysis of the Framingham population indicates that 
aortic stiffening precedes development of overt hypertension (3). 
In this regard, the tgsm/p22phox mouse recapitulates this sequence of 
events. At 6 months, aortic compliance is reduced in these ani-
Because isoketals are formed upon spontaneous rearrange-
ment of isoprostanes, we performed an additional study in which 
we measured plasma levels of F2-isoprostanes in 15 normotensive 
subjects and 28 patients with well-controlled hypertension. The 
general characteristics of these subjects are shown in Table 2. Age, 
BMI, fasting glucose, HbA1C, and systolic blood pressure were 
greater in the patient group than with the normotensive volunteers. 
Subjects in the hypertensive group were receiving between 2 and 4 
antihypertensive agents, including diuretics, calcium channel block-
ers, angiotensin I–converting enzyme inhibitors, angiotensin type 
1 receptor antagonists, and β-blockers. Overall, the hypertensive 
patients had increased levels of plasma F2-isoprostanes compared 
with normotensive subjects (10.7 ± 1.6 ng/ml vs. 17.7 ± 2.2 ng/ml, 
P < 0.05, Table 2). Importantly, there was highly significant correla-
tion between levels of plasma F2-isoprostanes and PWV for the entire 
cohort (Figure 13E), and this remained significant after adjusting for 
age, BMI, fasting glucose, and systolic blood pressure (Table 3).
Figure 10. Role of ROS and isoketals in vascular inflammation. Tgsm/p22phox mice were treated with tempol or 2-HOBA from 4–9 months of age. (A–C) Flow 
cytometric examples for leukocytes measured in single cells suspensions of aortas. (D–I) Mean data analyzed using 1-way ANOVA (n = 6–8). *P < 0.05; **P < 0.01.
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Figure 11. Cytokine production of T cells in the spleen of mice with chronic vascular oxidative stress. (A) Gating strategy for identifying T cell popu-
lations among total spleenocytes. Single cell suspensions were prepared from freshly isolated mouse spleens via enzymatic digestion and mechanical 
dissociation. (B–I) Intracellular staining indicating IL-17A (B, D–F) and IFN-γ (C, G–I) production in T cell subsets in WT and Tgsm/p22phox mice. Bar graphs were 
analyzed using 1-way ANOVA (n = 5–7). **P < 0.01.
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increased PWV and higher forward pressure wave amplitude, con-
tribute separately to the risk of adverse cardiovascular outcomes 
(3, 4). Of note, PWV is elevated in tgsm/p22phox mice at 6 months 
of age, prior to the development of renal inflammation, fibro-
sis, and dysfunction, supporting the notion that aortic stiffening 
directly causes renal damage and, ultimately, hypertension. Taken 
mals prior to development of hypertension. At 9 months, these 
mice develop modest elevations of blood pressure, while WT 
mice remain normotensive at this age. We also observed identi-
cal chronological changes in aortic stiffening and hypertension 
in mice with targeted vascular smooth muscle deletion of Sod3. 
Hemodynamic changes caused by aortic stiffening, including 
Figure 12. Tgsm/p22phox aortic homogenates prime DCs to promote T cell proliferation and activation. (A) Experimental design. Aortic homogenates from 
WT or tgsm/p22phox mice were used to prime naive DCs, which were then cocultured with T cells from these mice in various combinations. (B, C, F, and G) 
Flow cytometry and bar graphs identifying live CD3+ T cells and CD4+/CD8+ T cell subsets from cocultured DCs and T cells. (D, E, H, and I) Representative 
flow cytometry images and bar graphs showing percentages and numbers of proliferating CD4+ (D and H) and CD8+ (E and I) T cells, as determined using 
CSFE dilution (n = 6, 1-way ANOVA). Homo, homogenates. Black lines indicate original data, orange peaks indicate initial population, and purple peaks 
indicate generations of cells undergoing division as simulated by FlowJo 7.6.4 software. *P < 0.05 compared with Tgsm/p22phox homogenate + Tgsm/p22phox T 
cells; **P < 0.01 Tgsm/p22phox homogenate + Tgsm/p22phox T cells.
The Journal of Clinical Investigation   R e s e a R c h  a R t i c l e
6 3jci.org   Volume 126   Number 1   January 2016
This suggests that not only do DCs stimulate T cell proliferation 
and cytokine production, but also that T cells with T cell receptors 
that respond to isoketal adducts reciprocally activate DCs. One 
such signal might involve costimulatory engagement of DC B7 lig-
ands by T cell CD28, which we have previously shown to be critical 
for hypertension and T cell activation in this disease (32). In this 
regard, Orabona et al. have shown that CD28 can stimulate DCs 
to produce IL-6, IFN-γ, and to a lesser extent IL-23 in a B7 and p38 
MAP kinase–dependent fashion (33).
Macrophages and monocytes can also function as APCs and 
have the capability to trigger adaptive immune responses in addi-
tion to professional DCs (25). In the present study, we found an 
increase of total F4/80+ cells in the aorta of tgsm/p22phox mice with 
aging. In addition, we found that splenic macrophages and mono-
cytes of tgsm/p22phox mice accumulate isoketal adducts. We have 
previously shown that monocyte/macrophage-like cells do not 
increase expression of the B7 ligands, CD80 and CD86, in concert 
with their acquisition of isoketal adducts as robustly as DCs, sug-
gesting that they might not be as effective in T cell stimulation (18).
There is increasing awareness that posttranslational protein 
modification, such as citrullination and carbamylation, can lead to 
immune responses (34, 35). Our current and prior studies indicate 
that the covalent modification of self-proteins by isoketals might 
represent a similar phenomenon (36) and provide a mechanism by 
which chronic oxidative stress can lead to systemic immune acti-
vation. Despite the plethora of studies implicating ROS in diseases 
such as atherosclerosis, hypertension, and diabetes, several large 
clinical trials using either vitamin E or combinations of antioxi-
dants have failed to show any decrease in cardiovascular morbid-
ity or mortality (37, 38), and high doses of vitamin E have paradox-
ically been associated with increased cardiovascular event rates 
together, data from these 2 models suggest that mice with chronic 
vascular oxidative stress recapitulate age-related aortic stiffening 
and hypertension in humans and suggest that chronic vascular 
oxidative stress might contribute to the human disease.
Studies by our laboratory and others have implicated T cell–
derived cytokines in the development of tissue fibrosis and target 
organ damage in hypertension (13–16, 30). In the present study, we 
found that vascular oxidative stress induces production of IL-17A 
by splenic T cells. Moreover, DCs primed with aortic homogenates 
from tgsm/p22phox mice markedly activate T cells from this same geno-
type but not T cells from WT mice. This activation profile included 
not only proliferation, but also robust production of IL-17A, IL-17F, 
TNF-α, and IFN-γ. These observations support a pathway in which 
vascular oxidative stress leads to formation of isoketal-protein 
adducts that are taken up by DCs that, in turn, can activate T cells. 
Of note, we have previously shown that IL-17A induces fibroblast 
production of collagen via activation of p38 MAP kinase (15). Simi-
larly, Valente et al. have shown that IL-17A stimulates mouse cardiac 
fibroblast migration and proliferation via a p38 MAP kinase path-
way (31). IFN-γ also mediates cardiac inflammation and fibrosis in 
angiotensin II–infused WT mice, and IFN-γ receptor–deficient mice 
are protected from these changes (16). In addition, TNF-α has been 
implicated in angiotensin II–induced hypertension, and TNF-α 
antagonist treatment improves parameters of aortic compliance in 
humans with autoimmune disease (11, 13). Thus, the milieu of Th1/
Th17 cytokines stimulated by isoketal-adducted proteins likely pro-
motes age-related aortic stiffening and hypertension.
Related to the above considerations, a striking finding in the 
current study is the marked production of cytokines — including 
IL-1β, IL-6, TGF-β1, and GM-CSF — by DCs primed with tgsm/p22phox 
aortic homogenates when exposed to T cells from tgsm/p22phox mice. 
Table 1. Vascular oxidative stress–induced DC activation and cytokine production
Cytokine (pg/ml) WTA WTA Tgsm/p22phox A Tgsm/p22phox A Tgsm/p22phox + TempolA Tgsm/p22phox + 2-HOBAA
WTB Tgsm/p22phox B WTB Tgsm/p22phox B Tgsm/p22phox B Tgsm/p22phox B
GM-CSF 12.99 ± 1.42D 8.24 ± 2.18D 23.47 ± 11.17D 1450.50 ± 620.01 45.04 ± 28.71D 73.80 ± 58.52D
IL-1α 10.27 ± 4.23C 5.17 ± 1.71C 23.15 ± 10.99 44.43 ± 9.48 19.46 ± 9.40 14.40 ± 3.35
IL-1β 7.33 ± 2.58D 5.51 ± 1.97D 12.51 ± 4.59D 52.03 ± 8.80 14.96 ± 3.14D 17.41 ± 11.26D
IL-2 5.60 ± 1.48 16.92 ± 5.42 4.70 ± 1.25 8.26 ± 2.41 14.01 ± 6.02 15.16 ± 5.17
IL-6 20.63 ± 9.43D 28.64 ± 12.70D 39.10 ± 17.35D 1461.00 ± 439.78 122.42 ± 76.91D 215.62 ± 126.10D
IL-12(p40) 3.20 ± 0.00 3.20 ± 0.00 15.89 ± 12.69 4.03 ± 0.51 6.66 ± 2.77 3.20 ± 0.00
IL-12(p70) 3.20 ± 0.00 3.20 ± 0.00 5.25 ± 2.06 3.20 ± 0.00 3.55 ± 0.44 3.20 ± 0.00
IL-21 Undetectable Undetectable Undetectable Undetectable Undetectable Undetectable
IL-23 Undetectable Undetectable Undetectable Undetectable Undetectable Undetectable
TGF-β1 598.25 ± 89.60D 779.67 ± 79.89 733.25 ± 50.09C 1078.00 ± 121.93 807.20 ± 56.93 860.60 ± 75.65
TGF-β2 Undetectable Undetectable Undetectable Undetectable Undetectable Undetectable
TGF-β3 194.25 ± 5.92 184.33 ± 5.589D 189.00 ± 1.68C 218.00 ± 10.19 188.20 ± 4.859D 190.00 ± 3.54C
IL-17A 20.06 ± 2.27D 288.02 ± 223.47C 30.24 ± 11.86D 4433.50 ± 1871.88 219.88 ± 153.60D 298.38 ± 197.49D
IL-17F 4.23 ± 0.00D 49.49 ± 39.19D 15.80 ± 11.57D 920.00 ± 111.09 155.62 ± 124.28D 142.70 ± 88.87D
IFN-γ 3.20 ± 0.00D 38.47 ± 30.54D 4.87 ± 1.17D 3848.25 ± 2662.32 50.53 ± 52.53D 110.15 ± 72.34D
TNF-α 7.66 ± 2.54D 10.69 ± 5.07D 13.26 ± 5.14D 83.45 ± 8.10 21.73 ± 5.57D 23.58 ± 8.08D
T cells from either 9-month-old WT or Tgsm/p22phox mice were stimulated with DCs pulsed by aorta homogenate of WT mice, Tgsm/p22phox mice, and Tgsm/p22phox 
mice treated with tempol or 2-HOBA. Cytokines released into the culture medium were measured by a Luminex assay (n = 6). When values were not 
normally distributed, they were normalized by logarithmic transformation prior to 1-way ANOVA. ASources of aorta homogenate; BSources of T cells.  
CP < 0.05, DP < 0.01 vs. the combination of Tgsm/p22phox aorta homogenate and Tgsm/p22phox T cells.
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age were implanted with telemetry units. Ten days later, 
blood pressure was recorded for 10 minutes every hour 
for 3 days. In additional tgsm/p22phox mice, tempol (n = 6) or 
2-HOBA (n = 6) was administered in the drinking water 
from 4–9 months of age. In some experiments, 3-month-
old tgsm/p22phox × Rag-1–/– mice underwent adoptive trans-
fer of T cells as described previously (13, 15, 32). Nine-
month-old tgsm/p22phox × Rag-1–/– mice, with or without T 
cell reconstitution, were used for blood pressure and 
vascular stiffness measurements. Sod3fl/fl Smmhc-Cre 
mice and Sod3fl/fl × Cre– mice were treated with tamox-
ifen (3 mg/20 kg, dissolved in corn oil) via 5 consecutive 
i.p. injections at 10 weeks of age and were studied at 9 
months of age (21).
Power spectral analysis of heart rate variability. 
Blood pressure was recorded by telemetry for 5 minutes 
every hour at a sampling rate of 500 Hz, and data were 
extracted from waveform pressure. Heart rate variabil-
ity was analyzed from multiple artifact-free blood pres-
sure records of each mouse by LabChart Pro software 
(ADInstruments). Power spectra were calculated as pre-
viously described (21).
Ex vivo measurement of aortic stiffness. For studies 
of vascular stiffness, the descending thoracic aorta was 
mounted on cannulas at the in situ length in calcium-
free buffer (44). Intraluminal pressure was increased in a 
step-wise fashion while video microscopy was used to fol-
low wall thickness and vessel diameter. Diameters were 
recorded at increments of 25 mmHg from 0–200 mmHg. 
Stress-strain relationships were calculated as described 
by Baumbach et al. (44). Hydroxyproline was measured in 
isolated thoracic aortas as previously described (45–47).
In vivo measurement of PWV. PWV was measured 
using the transit time method with Doppler ultrasound 
(Vevo 2100, VisualSonics) as previously described (20). 
Briefly, mice were anesthetized with 2% isoflurane/air 
and maintained under light anesthesia. Mice were kept 
at supine positions on a heated platform (38°C) with ECG 
electrodes taped to their paws for continuous recordings. 
Thoracic and abdominal hair was removed. Pressure 
waveforms were imaged 1 mm below the exit to the left 
subclavian artery and 1 mm above the exit to left renal 
artery on the descending aorta. Arrival times were calcu-
lated based on the distances between the foot of the pres-
sure waveform and the peak of R wave for both the proximal and distal 
locations (Supplemental Figure 1B). The transit time was calculated as 
the difference in these arrival times and was averaged over 5 cardiac 
cycles. The in situ distances between these 2 positions were measured 
postmortem with a ruler. PWV (m/s) was calculated by dividing the 
distance by the transit time.
Flow cytometry. Single cell suspensions were prepared from aortas 
as previously described (15, 32). Briefly, the entire aorta with surround-
ing perivascular fat was minced with fine scissors and digested with 1 
mg/ml collagenase A, 1 mg/ml collagenase B, and 100 μg/ml DNAase 
I in phenol-free RPMI 1640 medium with 5% FBS for 30 minutes at 
37°C, with intermittent agitation. Fc receptors were blocked with 
CD16/CD32 for 20 minutes at 4°C (clone 2.4G2, BD Biosciences) prior 
(39), perhaps because ROS can have important signaling functions 
that modulate vascular tone, cell growth, and survival (40–42) and 
are critical for innate immunity. We have previously shown that 
these higher concentrations of vitamin E are required to suppress 
plasma F2 isoprostanes, which form from the same precursors as 
isoketals (43). It is therefore possible that agents such as 2-HOBA, 
which directly scavenge isoketals with a high rate constant and do 
not interfere with other ROS, will prove beneficial in treatment of 
disorders such as hypertension and aortic stiffening.
Methods
Animals. Male WT and tgsm/p22phox mice were studied at 3, 6, and 9 
months of age. For measurement of blood pressure, 6 mice at each 
Figure 13. Role of isoketal and oxidation in aortic collagen deposition and stiffening in 
humans. (A–D) Data from human aortas. (E) Comparison of PWV and isoprostane content 
in patients. Consecutive 6 μm sections were stained with anti-CD3, D-11 ScFv, and Mas-
son’s trichrome blue (A). Images are ×20 magnification. Scale bars: 100 μm. Image J was 
used to quantify the area of D-11 staining for isoketal adducts and the area of blue in the 
Masson’s trichrome stains. Human T cells were quantified by counting positively stained 
cells per ×20 field (B and C). Spearman’s correlations comparing PWV and 8-isoprostanes 
in normotensive and treated hypertensive humans (E). M, media; A, adventitia.
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5/7.1, BioLegend), AmCyan anti-F4/80 (clone BM8, BioLegend), and 
Alexa Fluor 700 anti–Ly-6C (clone AL-21, BD Biosciences) as previ-
ously described (25). A single chain antibody, D11 ScFv, was conju-
gated to Alexa Fluor 488 (catalog A10468, Invitrogen) for the detec-
tion of isoketals in these cells.
Measurement of isoketal adducts. Isoketals in mouse aortas were 
also measured as the isoketal-lysyl-lactam adducts using MS analy-
sis as previously described (18, 48). To detect DC isoketal adducted 
peptides by dot blot analysis, DCs from the spleen of 9-month-old 
WT or tgsm/p22phox mice were sorted using a Miltenyi Biotec DC iso-
lation kit to positively select IAb+/CD11b+/CD11c+ cells. The cells 
were placed in citrate-phosphate buffer at pH 3.3 containing a pro-
tease inhibitor cocktail and iodoacetamide (1:100) to elute MHC-
bound peptides. The peptides were then passed through ultrafiltra-
tion devices (Amicon Ultra, Millipore) to isolate peptides <5,000 Da 
and to remove β2-microglobulin proteins. Dot blot analysis was car-
ried out on the resulting flow-through to detect isoketal-adducted 
peptides using D11 ScFv.
T cell proliferation assay. Aorta homogenates were obtained 
from WT mice, tgsm/p22phox mice, or tgsm/p22phox mice chronically treated 
with tempol or 2-HOBA. Protein concentrations were determined 
in these samples using Bradford assay. CD11c+ DCs were isolated 
from total splenocytes of WT mice using a magnetic cell sorter and 
a commercially available kit (Miltenyi Biotec). This is an acceptable 
method to isolate essentially all DCs from mouse splenocytes. One 
million DCs were exposed to 100 mg aortic protein for 2 hours in 
RPMI 1640 with 10% FBS, 5% penicillin/streptomycin/fungizone, 
and 5% sodium pyruvate. These DCs were washed twice before 
being cocultured for 7 days with pan T cells prelabeled with CFSE 
(catalog C34554, Invitrogen). T cells were obtained from 9-month-
old WT mice or tgsm/p22phox mice that had either been untreated or 
chronically treated with tempol or 2-HOBA in the drinking water. 
Various combinations of aorta homogenate and T cells were 
employed as described in Figure 9, A and B. These cells were sub-
jected to flow cytometry analysis, and cytokines in the culture 
medium were measured by luminex.
to the staining of surface markers. The antibodies used were: Amcyan 
anti-CD45 (clone 2D1, BD Biosciences), PE anti-F4/80 (clone BM8, 
eBioscience), Pacific Blue anti-CD19 (clone 6D5, BioLegend), APC-
Cy7 anti-CD3e (clone 145-2C11, BD Biosciences), APC anti-CD4 
(clone GK1.5, eBioscience), and PE-Cy7 anti-CD8a (clone 53-6.7, BD 
Biosciences). Cells (1 × 106) were incubated with 1.5 μl of each anti-
body in 100 μl of FACS buffer for 35 minutes. The cells were then 
washed twice with FACS buffer and immediately analyzed on a FACS-
Canto flow cytometer with DIVA software (BD Biosciences). Dead 
cells were eliminated from analysis using 7-AAD (catalog 559925, 
BD Biosciences). For each experiment, we performed flow minus one 
(FMO) controls for each fluorophore to establish gates. Data analysis 
was performed using FlowJo software (Tree Star Inc.).
Intracellular staining of splenocytes. Splenocytes (1 × 106) were 
resuspended in RPMI medium supplemented with 5% FBS and stim-
ulated with ionomycin and phorbol myristate acetate and brefeldin 
A at 37°C for 5 hours. Dead cells were excluded from analysis with 
a fixable Violet dead cell stain. The following surface antibodies 
were employed for staining T cells: BV510 anti-CD45 (clone 2D1, 
BD Biosciences), PerCP-Cy5.5 anti-CD3e (clone 145-2C11, BD Bio-
sciences), PE-Cy7 anti-CD8a (clone 53-6.7, BD Biosciences), and 
APC-H7 anti-CD4 (clone GK1.5, BD Biosciences). Intracellular stain-
ing was then performed with the Cytofix/Cytoperm Plus fixation/
permeabilization solution kit (BD Biosciences) using PE anti–IL-17A 
(clone eBio17B7, eBioscience), and FITC anti–IFN-γ antibodies (clone 
XMG1.2, eBioscience). In some experiments, macrophages, DCs, and 
monocytes were gated using APC anti-CD11b (clone M1/70, BD Bio-
sciences), PE anti-MerTK (clone HMER5DS, eBioscience), APC-Cy7 
anti-CD11c (clone HL3, BD Biosciences), PerCP-Cy5.5 MHC-II/I-A b 
(clone M5/114.15.2, BD Biosciences), PE-Cy7 anti-CD64 (clone X54-
Table 2. Characteristics of study groups
NT (n = 15) HTN (n = 28)
Age (year) 50.9 ± 5.7 58.1 ± 11.2A
Sex (female/male) 13/15 8/7
BMI (kg/m2) 25.2 ± 2.6 29.9 ± 5.4A
Office SBP (mmHg) 120 ± 14 129 ± 9A
Office DBP (mmHg) 77 ± 9 80 ± 8
PWV (m/s) 7.2 ± 0.9 8.8 ± 1.7A
Fasting glucose (mg/dl) 83.7 ± 9.1 99.5 ± 18.5A
HbA1C (%) 5.2 ± 0.2 6 ± 0.6A
Total cholesterol (mg/dl) 212 ± 41 206 ± 38
LDL (mg/dl) 129 ± 38 128 ± 31
F2-isoprostanes (ng/ml) 10.7 ± 1.6 17.7 ± 2.2A
Drugs
Thiazide diuretics (%) 0 70
ACEi (%) 0 30
ARB (%) 0 41
CCB (%) 0 30
β-blockers (%) 0 41
Other anti-HT drugs (%) 0 7
NT, normotensive subjects; HT, patients with well-controlled hypertension; 
SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1C, glycated 
hemoglobin; ACEi, angiotensin I–converting enzyme inhibitor; ARB, 
angiotensin receptor blocker; CCB, calcium channel blocker. AP < 0.05.
Table 3. Multiple linear regressions for the association between 
log-transformed plasma 8-isoprostane levels and arterial 
stiffness
β SEM P value
Unadjusted model
Constant 0.772 0.0483 <0.001
Log 8-isoprostane 0.123 0.0427 0.006A
Adjusted model
Constant 0.497 0.122 <0.001
Log 8-isoprostane 0.102 0.038 0.010A
Age (year) 0.0040 0.0011 <0.001A
BMI (kg/m2) 0.00143 0.0024 0.557
SBP (mmHg) 0.00004 0.0009 0.968
Fasting glucose (mg/dl) 0.0003 0.0007 0.694
Unadjusted model R = 0.411, R2 = 0.169, adjusted R2 = 0.148. Adjusted 
model, R = 0.681, R2 = 0.463. Adjusted R2 = 0.389. β, beta coefficient; SEM, 
standard error; SBP, systolic blood pressure. n = 43. AP < 0.05.
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roni post hoc test when significance was indicated. To compare 
the effect of age on various mouse strains, 2-way ANOVA was 
employed. To compare the effects of antioxidant treatments 
and the effect of Rag-1 deficiency, 1-way ANOVA was per-
formed. The values of cytokines were normalized with loga-
rithmic transformation prior to 1-way ANOVA. Correlations 
between immune-staining parameters were made using Spear-
man’s correlation analysis. Multivariate regression was used 
for analysis of human data. P values are reported in the figures.
Study approval. All animal procedures were approved 
by Vanderbilt University’s Institutional Animal Care and 
Use Committee, and the mice were housed and cared for 
in accordance with the Guide for the Care and Use of Lab-
oratory Animals, US Department of Health and Human Ser-
vices. The institutional review boards of Washington Univer-
sity and the University of Campinas approved the respective 
human studies. Subjects enrolled at Campinas signed a writ-
ten informed consent form before enrolling in the study.
Author contributions
JW, MAS, AK, HAI, KRCM, LX, WC, SSD, and NRB per-
formed experiments, analyzed data, and participated in 
manuscript preparation. SSD and LJR performed MS. JJG, 
CMW, KEB, LJR, HM, HC, MSM, and DGH participated 
in study design and manuscript preparation and obtained 
funding for the study. JAC provided human samples and 
assisted in manuscript preparation. HM supervised and 
obtained funding for human studies of PWV. RLM pro-
duced and provided the D11 antibody and assisted in 
experimental design.
Acknowledgments
We are grateful to the Transitional Pathology Shared Resource 
(TPSR) core and the Epithelial Biology Center at Vanderbilt Uni-
versity for assistance with imaging and quantification of immuno-
histochemical staining. We also thank the Vanderbilt University 
Medical Center Hormone Assay and Analytical Services Core 
(supported by NIH grants DK059637 and DK020593), who per-
formed the cytokine measurements. We thank William Zackert 
for performing the MS and IHC for isoketal in the aorta samples. 
We also thank Zhizhang Wang in the Division of Cardiovascular 
Medicine at Vanderbilt University for his assistance in conducting 
in vivo measurement of PWV. This work was supported by NIH 
R01 grants HL105294, HL039006, and HL108701; VITA contract 
HHSN268201400010C; Program Project grants P01 HL58000 
and GM015431; an American Heart Association predoctoral fel-
lowship to J. Wu (13PRE14480008); and postdoctoral fellowship 
awards to A. Kirabo and M.A. Saleh. M.S. Madhur is the recipient 
of NIH K08 award (1K08HL121671) and a Vanderbilt Physician 
Scientist Development Award. H.A. Itani is supported by NIH F32 
training grant (1F32HL124972-01).
Address correspondence to: David G. Harrison, Betty and Jack 
Bailey Professor of Medicine and Pharmacology, Director of 
Clinical Pharmacology, Room 536 Robinson Research Building, 
Vanderbilt University, Nashville, Tennessee 37232-6602, USA. 
Phone: 615.875.3049; E-mail: david.g.harrison@vanderbilt.edu.
IHC of mouse tissues. Consecutive 6-micron sections were 
obtained from paraffin-embedded mouse thoracic aorta and kid-
ney. These sections were stained with anti-CD3 (clone 145-2C11, BD 
Biosciences), D-11 ScFv, and Masson’s trichrome blue as previously 
described (18, 49). Image J was used to quantify the area of D-11 
staining for isoketal adducts and the area of blue in the Masson’s tri-
chrome stains per 20× field.
Human studies. PWV was measured using the SphygmoCor Sys-
tem (AtCor Medical). Venous blood samples were collected in tubes 
containing heparin. Plasma 8–isoprostane was detected by an enzyme 
immunoassay EIA kit (Cayman Chemical).
Human aortic tissue samples were obtained by one of the authors 
(J.A. Curci) during the course of open revascularization procedures 
for atherosclerotic occlusive disease of the aorta or at the time of 
renal transplantation at Washington University, St Louis, Missouri, 
USA. All specimens were full thickness infrarenal aortic tissue that 
was discarded at the time of the procedure by the clinical team and 
were anonymously transferred to the laboratory for study. Portions 
of these tissue samples were fixed in formalin, embedded in paraffin, 
and sliced into 6-micron sections. Consecutive sections were stained 
with anti-CD3 (clone HIT3a, BD Biosciences), D-11 ScFv, and Mas-
son’s trichrome blue as previously described (18, 49). Human T cells 
were quantified by counting the number of positively stained cells per 
20× field. Five representative fields were quantified for each sample.
Statistics. Data in the manuscript are represented as mean ± SEM. 
Comparisons of blood pressure over time and aortic mechanics were 
made using 1-way ANOVA for repeated measures, followed by a Bonfer-
Figure 14. Proposed pathway. Chronic vascular oxidative stress leads to formation of 
immunogenic isoketal-protein adducts, which accumulate in DCs and promote T cell 
activation. Activated T cells accumulate in perivascular tissues and release cytokines 
that enhance collagen deposition and aortic stiffening. This enhances pulse wave veloc-
ity. Renal inflammation and fibrosis follows these events, leading to overt hypertension.
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